If you are looking for someone who is a perfect example of what a true entrepreneur looks like, then you need to look no further then at Dr. Mark McKenna. McKenna was an exceptional student while enrolled at Tulane Medical School, but it wasn’t long before he quickly realized that in order to make money he would have to venture out beyond medicine. Even while he was still in medical school, he would moonlight at prisons doing physicals and invested every but of money that he made on the side into real estate.

He graduated with his medical degree in 1999 and did work a few years in his father’s practice, but it was not long before Dr. Mark McKenna turned all of his attention to building a successful real estate business. This business did suffer a huge hit from Hurricane Katrina though and McKenna lost millions due to damage from the storm. At this point in his life, McKenna decided to combine his medical background with his business spirit and created ShapeMed. ShapeMed was a set of offices that offered aesthetic treatments for those who wished to enhance their appearances. In 2015, he decided to sell the successful ShapeMed brand to a successful chain of gyms and that is when he came up with his newest business venture, OVME.

OVME, is a cosmetic medical office currently located in Atlanta, Georgia; however, Dr. Mark McKenna has the hope that eventually his idea will become a national chain of aesthetic medical offices. OVME will provide individualized aesthetic medical treatment for those consumers who wish to build their self-confidence. He also plans to eventually develop an application for smart devices, so that individuals can search for aesthetic practitioners that can complete simple treatments in the privacy of someone’s home.

Dr. Mark McKenna is a man of intelligence and of immense drive. If you need someone to look at as a role model for leading in the entrepreneur world, then McKenna is that person.

http://www.theglobaldispatch.com/dr-mark-mckenna-opens-ovme-clinic-in-buckhead-10480/

Paragon a biosciences company started by Jeff Aronin in 2010. This company is one of the leading innovative companies in creating healing medications for human diseases that previously not been cured. Jeff Aronin founded Paragon Biosciences to find the cure to diseases by creating the right medicines through research of the particular debilitating diseases that patients have. Paragon Biosciences partners with other entrepreneurs and their companies to provide the absolute best for the patients that can use the much-needed medications.

Jeff Aronin has lead various pharmaceuticals companies during his time in the industry. He is an expert in bringing together the right teams of people that are dedicated to finding the real medical solutions to these rare diseases together. Since Paragon Biosciences and its partner companies have been working together along with Jeff Aronin leadership, thirteen medications have been approved by the FDA for use for patients with diseases that have otherwise been looked over by other medical professionals.

Without Jeff Aronin and partnered companies dedicated to helping patients first with debilitating diseases, such as Epidermolysis Bullosa, better known as EB, would go untreated (http://www.wikidot.com/user:info/jeffaronin). This rare skin disease causes painful blisters all over the skin and the internal organs because of the trauma to the body that the disease symptoms give. This disease can be inherited from family and twenty-five thousand people suffer from it in the United States.

In recent news, one of Jeff Aronin’s founding companies Castle Creek Pharmaceuticals that is a part of Paragon Biosciences is holding a 5th annual dermatology Summit that helps fund all of the organizations continued success in finding medicines that work for patients that are turned away with seemingly incurable diseases because it is no known cure. Paragon Biosciences is making it easy for millions of people lives throughout out the world with their never-ending dedication to the research to find the cure for rare human diseases.